Benzodiazepines are different from many substances that bring people into addiction treatment because physical dependence can develop even when someone takes the medication exactly as prescribed. A person may become dependent on alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), or another benzodiazepine without ever misusing it or trying to get high.
That can make the problem easy to miss. The medication still comes from a pharmacy, the bottle has the patient’s name on it, and a physician originally prescribed it. Yet reducing or stopping the medication may now cause severe anxiety, insomnia, shaking, or other withdrawal symptoms. Abrupt benzodiazepine withdrawal can also be medically dangerous.
Dependence Is Not the Same as Addiction
Physical dependence means the body has adapted to the medication and withdrawal develops when the dose is reduced or stopped. Benzodiazepine use disorder involves a problematic pattern of use, such as losing control over the amount taken, compulsive use, taking more than prescribed, obtaining medication from multiple sources, or continuing despite significant harm.
A patient can be physically dependent without having an addiction. Regular benzodiazepine use commonly produces physical dependence, while only a minority of patients develop benzodiazepine use disorder.
Someone who cannot abruptly stop Xanax is therefore not automatically “addicted.” The distinction matters because the treatment plan may be very different.
“But the Doctor Prescribed It” Can Delay Recognition
Benzodiazepines can occupy a different category from “drugs” in many families. Someone taking clonazepam every night for anxiety, panic attacks, or insomnia may not consider it a substance problem because the medication entered their life through legitimate medical treatment.
This can be particularly relevant in South Asian families where psychiatric symptoms may be described as “tension,” stress, headaches, weakness, or sleep problems rather than as anxiety or another mental health condition. Taking medication may feel more acceptable than discussing the diagnosis behind it.
A legitimate prescription does not prevent physical dependence from developing.
Xanax Can Become Difficult to Stop
Alprazolam, commonly sold as Xanax, can be particularly difficult to taper for some patients because it is relatively short-acting.
A person may begin noticing anxiety or other symptoms before the next dose. They take another tablet and feel better. Over time, it can become difficult to distinguish the original anxiety disorder from withdrawal symptoms developing as the medication level falls.
This can create the impression that Xanax is the only thing controlling the person’s anxiety when part of the relief may also be treatment of emerging withdrawal.
Withdrawal Can Look Like the Original Problem Returning
Common benzodiazepine withdrawal symptoms can include:
- anxiety or panic;
- insomnia;
- irritability;
- tremor;
- restlessness;
- difficulty concentrating;
- muscle pain or stiffness;
- nausea;
- increased sensitivity to light or sound; and
- perceptual disturbances.
A patient who originally received clonazepam for anxiety may reduce the medication, develop severe anxiety, and conclude that they still need the medication.
Sometimes they do. The underlying anxiety disorder may still require treatment. In other cases, withdrawal is contributing substantially. Both problems may be present at the same time.
Do Not Abruptly Stop Benzodiazepines After Regular Use
Abrupt discontinuation or an excessively rapid dose reduction can cause severe withdrawal, including seizures, delirium, hallucinations, psychosis, and other potentially life-threatening complications.
Patients who have taken benzodiazepines regularly for more than about a month generally should not stop suddenly without medical guidance.
There is no universal taper schedule. Current clinical guidance often begins with relatively small dose reductions and then adjusts the pace according to the patient’s symptoms and risk factors. Some patients require much slower reductions.
A taper should be individualized based on factors such as:
- the specific benzodiazepine;
- current dose;
- duration of use;
- previous withdrawal symptoms;
- other medications;
- alcohol or other substance use;
- medical conditions; and
- psychiatric history.
A taper described online should not be copied and applied without clinical assessment.
Families Can Accidentally Make Withdrawal More Dangerous
A common reaction to discovering benzodiazepine misuse is to take the medication away immediately.
With benzodiazepines, that can be dangerous.
A parent may discover that an adult child is taking much more Xanax than prescribed and confiscate the pills. A spouse may find hidden bottles and lock away the medication. If physical dependence is present, suddenly removing access can trigger significant withdrawal.
The safer approach is to determine what the person is actually taking, how much, how often, for how long, and from which sources, then obtain medical guidance.
The Family May Not Know the Real Dose
Assessment can be difficult when the prescription represents only part of someone’s benzodiazepine use.
A patient may have a legitimate prescription but also take additional tablets obtained elsewhere. They may alternate Xanax and clonazepam, combine benzodiazepines with alcohol, or take pills without knowing exactly what they contain.
An accurate withdrawal plan depends on having a reasonably accurate estimate of total exposure.
Illicit pills create an additional risk because counterfeit tablets sold as Xanax may contain fentanyl or other unexpected substances. That changes both overdose risk and treatment planning.
Patients should disclose everything they are taking. The purpose is not to catch someone being dishonest. It is to avoid creating a medically unsafe plan based on incomplete information.
Alcohol and Benzodiazepines Are a High-Risk Combination
Benzodiazepines and alcohol both depress the central nervous system. Combining benzodiazepines with alcohol, opioids, or other sedating substances substantially increases the risk of respiratory depression, overdose, and death.
Alcohol history also matters when assessing benzodiazepine withdrawal. A history of severe alcohol withdrawal, withdrawal seizures, or delirium can increase concern for complicated withdrawal and may affect whether outpatient treatment is appropriate.
Some Patients Need More Than an Outpatient Taper
Many patients can taper benzodiazepines safely in outpatient care. Others need a higher level of medical supervision.
More intensive care may be appropriate when there is:
- a history of withdrawal seizures or delirium;
- very high or uncertain benzodiazepine intake;
- severe withdrawal symptoms;
- unstable medical or psychiatric illness;
- significant overdose risk;
- substantial use of alcohol, opioids, or other substances;
- suicidal behavior or serious safety concerns; or
- inability to follow a taper safely outside a structured setting.
A benzo rehab should not simply remove the medication and wait for withdrawal to pass. The first decision is whether the patient needs medically managed withdrawal, residential treatment, outpatient tapering, or a combination over time.
South Asian Families May Minimize the Medication and Stigmatize the Treatment
Some families are comfortable with years of prescribed medication for “tension” or sleep but view seeing a psychiatrist, addiction specialist, or entering residential treatment as far more serious.
Mental health stigma can also create concerns about family reputation, marriage, or other relatives finding out. This can produce a situation where dependence remains hidden for years while seeking appropriate treatment feels like the embarrassing part.
Medical assessment should be treated as the responsible response to dependence, not as evidence that the patient has failed.
Treatment Should Address Why the Benzodiazepine Became Important
A taper can address physical dependence without necessarily addressing the reason the medication became important in the first place.
Someone who began Xanax because of severe panic attacks still needs treatment for panic. Someone taking clonazepam nightly because they cannot sleep needs an insomnia plan. A person who began using benzodiazepines during trauma, depression, family conflict, or severe stress may need therapy or psychiatric treatment alongside the taper.
Patients with benzodiazepine use disorder may also need broader addiction treatment addressing cravings, compulsive use, other substances, triggers, family dynamics, and relapse prevention.
Benzodiazepine treatment is therefore more than calculating progressively smaller doses. It should address both the physical dependence and the problem the medication was originally being used to manage.
Benzodiazepine Assessment at South Asian Recovery Center
South Asian Recovery Center is a physician-owned and managed residential substance use treatment facility in Los Angeles created for South Asian individuals and families. Treatment includes medical evaluation and management, structured individual and group counseling, family involvement when appropriate, case management, and continuing-care planning.
With benzodiazepines, the first priority is determining the appropriate level of care. A patient who is physically dependent while taking medication exactly as prescribed may need a very different plan from someone taking large amounts of nonprescribed Xanax while also using alcohol or other drugs.
Cultural context can matter as well. Families may need help understanding that dependence can develop from legitimate medical treatment, that a supervised taper is not a sign of weakness, and that medical assessment is safer than attempting an abrupt stop at home.
If Xanax, clonazepam, lorazepam, or another benzodiazepine has become difficult to reduce, seek medical assessment rather than stopping abruptly. Contact South Asian Recovery Center (SARC) to discuss whether residential treatment or another level of care may be appropriate.